Biopharmaceutical Analysis

Feliza Mirasol is the science editor for 

Articles

Preclinical testing is better able to evaluate complex drug candidates thanks to innovations in animal model approaches.

Animal Models Are Seeing Upgrades to Tackle Complex Molecule Testing

Mili Pathak is principal scientist, Process Science, R&D, at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Prashant Pokhriyal is associate scientist at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Ronak Patel is principal scientist, R&D, at Intas Pharmaceuticals (Biopharma Division), Ahmedabad, Gujarat, India.

Laxmi Adhikary, PhD, is senior vice-president, R&D, at Intas Pharmaceuticals (Biopharma Division), Ahmedabad, Gujarat, India.

The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.

Do Modeling and Simulation Tools Really Benefit the Biosimilar Industry?

Andrew Feilden is the European E&L strategic director for Element.

By understanding potential material change, the impact on patient safety can be understood and mitigated.

Material Management and the Impact on Extractables and Leachables

Bio-Rad’s SEQuoia Express Stranded RNA Library Prep Kit is designed to construct efficient RNA sequencing workflows.

Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit

Marwan Alsarraj is the Biopharma Segment manager at Bio-Rad.

One get obtain a clearer assessment of gene-editing outcomes through more exacting analytical tools.



Using ddPCR to Assess the Success of CRISPR Gene Therapies

One can use modeling methods to generate data and shorten development timelines in preclinical studies.

Adopting a Modeling Approach for Preclinical Studies

Applying modeling methods in preclinical studies can be a powerful tool for generating data and shortening development timelines.

Using a Modeling Approach to Preclinical Studies

Ryan Burke is the environmental monitoring manager for Element Materials Technology.

Madison Prifti is the senior environmental monitoring analyst for Element Materials Technology.

Effective cleaning and disinfection along with contamination controls are imperative when operating and utilizing a cleanroom.

Cleanroom Cleaning: Proper Methodology and Determining Efficacy

Bio-Rad has launched a range of antibodies specifically for daratumumab that inhibit the binding of the drug to the target antigen, CD38, which allows for highly specific bioanalysis and drug monitoring.

Bio-Rad Offers a Range of Anti-Daratumumab Antibodies Specific for Daratumumab

Editor of Pharmaceutical Technology Europe

Scientists can work to overcome the challenges associated with protein characterization through empowering technologies.

Analytical Methods